On April 25, 2021, I recommended ticker symbol INVA as a good ‘buy and hold’ stock at/or below $11.71/share.
Innoviva, Inc. (INVA) is a leading bio-pharmaceuticals firm based in California. Backed by impressive growth numbers (sales and earnings per share) INVA’s management team has done a great job of reinvesting in key growth areas.
⇒ Price: $11.70
⇒ Target: $36
⇒ Current: yahoo finance